BioCardia is a regenerative medicine company developing therapeutics for cardiovascular diseases with unmet medical needs. It offers biotherapeutic solutions for cardiovascular disease in its CardiAMP and CardiALLO therapies.
Type | Private | |
Founded | 2002 | |
HQ | San Carlos, CA, US | Map |
Website | biocardia.com |
Founding Date | 2002 |
BioCardia latest funding size | $7.40 m |
USD | |
---|---|
Revenue (Q2, 2020) | 27.0k |
Net income (Q2, 2020) | (3.6m) |
EBIT (Q2, 2020) | (3.6m) |
Cash (30-Jun-2020) | 11.1m |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 137.0k | 112.0k | 130.0k | 199.0k | 239.0k | 84.0k | 216.0k | 86.0k | 194.0k | 38.0k | 27.0k |
Cost of goods sold | 175.0k | 203.0k | 147.0k | 157.0k | 135.0k | 109.0k | 106.0k | 191.0k | 24.0k | 4.0k | |
Gross profit | (38.0k) | (91.0k) | (17.0k) | 42.0k | 104.0k | (25.0k) | 110.0k | (105.0k) | 170.0k | 34.0k | |
Gross profit Margin, % | (28%) | (81%) | (13%) | 21% | 44% | (30%) | 51% | (122%) | 88% | 89% |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 19.0m | 15.1m | 13.3m | 9.7m | 6.8m | 4.8m | 2.8m | 517.0k | 8.9m | 2.6m | 11.1m |
Accounts Receivable | 121.0k | 142.0k | 90.0k | 127.0k | 191.0k | 170.0k | 287.0k | 204.0k | 103.0k | 179.0k | 214.0k |
Prepaid Expenses | 252.0k | 282.0k | 188.0k | 277.0k | 282.0k | 224.0k | |||||
Inventories | 144.0k | 193.0k | 240.0k | 148.0k | 136.0k | 134.0k | 118.0k | 5.0k | 45.0k |
USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (2.9m) | (5.8m) | (8.8m) | (3.6m) | (6.8m) | (10.3m) | (3.7m) | (7.4m) | (11.2m) | (4.6m) | (8.2m) |
Depreciation and Amortization | 13.0k | 36.0k | 57.0k | 22.0k | 44.0k | 66.0k | 23.0k | 49.0k | 78.0k | 22.0k | 36.0k |
Inventories | (9.0k) | (58.0k) | (105.0k) | 43.0k | 55.0k | 57.0k | 23.0k | 85.0k | 43.0k | 1.0k | 1.0k |
Accounts Payable | (249.0k) | 60.0k | (80.0k) | (164.0k) | (390.0k) | 200.0k | 122.0k | 609.0k | 372.0k | 194.0k | 610.0k |
USD | Q1, 2017 |
---|---|
Financial Leverage | 1.1 x |
When was BioCardia founded?
BioCardia was founded in 2002.
Who are BioCardia key executives?
BioCardia's key executives are Peter Altman, Eric Duckers and David McClung.
How many employees does BioCardia have?
BioCardia has 27 employees.
What is BioCardia revenue?
Latest BioCardia annual revenue is $710 k.
What is BioCardia revenue per employee?
Latest BioCardia revenue per employee is $26.3 k.
Who are BioCardia competitors?
Competitors of BioCardia include FIRE1, ReShape Lifesciences and HDL Therapeutics.
Where is BioCardia headquarters?
BioCardia headquarters is located at 125 Shoreway Rd Suite B, San Carlos.
Where are BioCardia offices?
BioCardia has an office in San Carlos.
How many offices does BioCardia have?
BioCardia has 1 office.
Receive alerts for 300+ data fields across thousands of companies